Yakira Capital Management’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Yakira Capital Management’s Portfolio NRXPW Stock Details NRXPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,409	Closed	-$2K	–	312
2023 Q4	$2K	Sell	15,409 -1,720	-10%	-$166	﹤0.01%	287
2023 Q3	$1.37K	Hold	17,129	–	–	﹤0.01%	347
2023 Q2	$4.28K	Hold	17,129	–	–	﹤0.01%	297
2023 Q1	$3.08K	Hold	17,129	–	–	﹤0.01%	344
2022 Q4	$4.28K	Hold	17,129	–	–	﹤0.01%	312
2022 Q3	$5K	Hold	17,129	–	–	﹤0.01%	390
2022 Q2	$2K	Hold	17,129	–	–	﹤0.01%	425
2022 Q1	$15K	Sell	17,129 -8,919	-34%	-$13.1K	﹤0.01%	423
2021 Q4	$48K	Sell	26,048 -3,000	-10%	-$9.49K	0.01%	363
2021 Q3	$139K	Sell	29,048 -11,652	-29%	-$71.9K	0.02%	287
2021 Q2	$145K	Hold	40,700	–	–	0.02%	284
2021 Q1	$396K	Hold	40,700	–	–	0.08%	218
2020 Q4	$191K	Sell	40,700 -41,800	-51%	-$46.9K	0.05%	208
2020 Q3	$21K	Hold	82,500	–	–	0.01%	233
2020 Q2	$37K	Hold	82,500	–	–	0.02%	148
2020 Q1	$5K	Hold	82,500	–	–	﹤0.01%	151
2019 Q4	$15K	Hold	82,500	–	–	﹤0.01%	148
2019 Q3	$14K	Hold	82,500	–	–	﹤0.01%	147
2019 Q2	$18K	Hold	82,500	–	–	﹤0.01%	144
2019 Q1	$15K	Hold	82,500	–	–	﹤0.01%	122
2018 Q4	$32K	Hold	82,500	–	–	0.01%	122
2018 Q3	$34K	Hold	82,500	–	–	0.01%	134
2018 Q2	$31K	Hold	82,500	–	–	0.01%	127
2018 Q1	$31K	Hold	82,500	–	–	0.01%	126
2017 Q4	$38K	Buy	+82,500	New	+$31.4K	0.01%	110

Other funds holding NRXPW

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Yakira Capital Management's NRXPW Position: Q1 2024 in Review

Yakira Capital Management sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q1 2024, closing a stake of 15,409 shares — an estimated $2K sold.

Yakira Capital Management first reported a position in NRXPW in Q4 2017 and held it in 25 quarters. The position peaked at $396K in Q1 2021. 4 funds tracked by Wall St. Rank hold NRXPW as of Q1 2024.

Yakira Capital Management reported no remaining NRX Pharmaceuticals Warrant position as of Q1 2024 after selling out during the quarter.
Yakira Capital Management sold 15,409 NRX Pharmaceuticals Warrant shares in Q1 2024, an estimated $2K.
Yakira Capital Management first reported a position in NRX Pharmaceuticals Warrant in Q4 2017 and held it in 25 quarters.
Yakira Capital Management's NRX Pharmaceuticals Warrant position peaked at $396K in Q1 2021.
4 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q1 2024.

Based on Yakira Capital Management's 13F filing for Q1 2024, filed 14 May 2024.